Skip to main content

UNC Pharmacy's Library tagged "Jian Liu"   View Popular, Search in Google

Apr 05, 13

Impending federal budget cuts could mean more than a loss of research money for the University - they could also slow the development of life-saving drugs
. . .
One of these researchers is Jian Liu, a professor in the UNC School of Pharmacy, who received NIH funding in 2009 for his work on creating a synthetic version of the blood-thinner heparin.

The funding cycle ended in January, and Liu said if he doesn't get additional money, residual funds will only support his work for another six months.

Mar 11, 13

The Chronicle of Higher Education interviewed Jian Liu for a March 11, 2013, story about the potential effect of the sequestration on colleges and universities.

Mar 06, 13

Professor Jian Liu discussed with CNN Money the effect the sequestration might have on his research.

Nov 07, 11

Technology Review reported on Jian Liu's creation of a simpler, safer synthetic heparin.

Nov 07, 11

Chapelboro.com reported on Jian Liu's creation of a simpler, safer synthetic heparin.

Nov 07, 11

The Royal Society of Chemistry reported on Jian Liu's creation of a simpler, safer synthetic heparin.

Nov 07, 11

News-medical.net reported on Jian Liu's creation of a simpler, safer synthetic heparin.

Nov 07, 11

Health Canal reported on Jian Liu's creation of a simpler, safer synthetic heparin.

Nov 07, 11

Drug Discovery & Development reported on Jian Liu's creation of a simpler, safer synthetic heparin.

Aug 11, 09

Jian Liu, PhD, was quoted in a Scientific American article on the search for synthetic heparin.

Aug 11, 09

Jian Liu was cited in a March 26, 2008, article in The Globe and Mail (Toronto) about problems with the heparin supply chain in China.

Aug 11, 09

Jian Liu was cited in a March 20, 2008, article in The Wall Street Journal about problems with the heparin supply chain in China.

Aug 11, 09

Jian Liu was interviewed for a front-page story in the February 28, 2008, edition of the New York Times, about problems with the heparin supply chain in China.

1 - 16 of 16
20 items/page

Diigo is about better ways to research, share and collaborate on information. Learn more »

Join Diigo